Compton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,635
Closed -$561K 29
2023
Q1
$561K Sell
1,635
-6,040
-79% -$2.04M 1.21% 26
2022
Q4
$2.81M Sell
7,675
-900
-10% -$319K 2.02% 13
2022
Q3
$2.77M Hold
8,575
1.86% 12
2022
Q2
$2.78M Sell
8,575
-821
-9% -$246K 1.53% 19
2022
Q1
$2.69M Hold
9,396
0.75% 37
2021
Q4
$2.6M Sell
9,396
-82
-0.9% -$20.8K 0.67% 39
2021
Q3
$2.19M Hold
9,478
0.64% 40
2021
Q2
$2.17M Sell
9,478
-175
-2% -$35.2K 0.64% 42
2021
Q1
$1.8M Buy
9,653
+2,500
+35% +$489K 0.57% 49
2020
Q4
$1.21M Hold
7,153
0.41% 59
2020
Q3
$1.06M Hold
7,153
0.41% 58
2020
Q2
$1.17M Hold
7,153
0.49% 55
2020
Q1
$992K Sell
7,153
-100
-1% -$13.7K 0.49% 58
2019
Q4
$953K Buy
7,253
+5,100
+237% +$591K 0.37% 68
2019
Q3
$241K Hold
2,153
0.1% 125
2019
Q2
$239K Buy
2,153
+400
+23% +$47.1K 0.1% 123
2019
Q1
$227K Sell
1,753
-50
-3% -$6.08K 0.1% 123
2018
Q4
$209K Buy
+1,803
New +$201K 0.1% 134

Other funds holding LLY

Compton Capital Management's LLY Position: Q2 2023 in Review

Compton Capital Management sold out of Eli Lilly (LLY) in Q2 2023, closing a stake of 1,635 shares — an estimated $561K sold.

Compton Capital Management first reported a position in LLY in Q4 2018 and held it in 18 quarters. The position peaked at $2.81M in Q4 2022. 2,815 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Compton Capital Management reported no remaining Eli Lilly position as of Q2 2023 after selling out during the quarter.
  • Compton Capital Management sold 1,635 Eli Lilly shares in Q2 2023, an estimated $561K.
  • Compton Capital Management first reported a position in Eli Lilly in Q4 2018 and held it in 18 quarters.
  • Compton Capital Management's Eli Lilly position peaked at $2.81M in Q4 2022.
  • 2,815 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Compton Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.